3TKD
Crystal structure of the GluA2 ligand-binding domain (S1S2J-L483Y-N754S) in complex with glutamate and cyclothiazide at 1.45 A resolution
3TKD の概要
| エントリーDOI | 10.2210/pdb3tkd/pdb |
| 関連するPDBエントリー | 1LB9 1LBB 1LBC 3H6T 3IL1 |
| 分子名称 | GLUTAMATE RECEPTOR 2, GLUTAMIC ACID, CYCLOTHIAZIDE, ... (6 entities in total) |
| 機能のキーワード | ampa receptor ligand-binding domain, glua2 s1s2j-l483y-n754s, cyclothiazide, allosteric modulation, membrane protein |
| 由来する生物種 | Rattus norvegicus (rat) 詳細 |
| 細胞内の位置 | Cell membrane; Multi-pass membrane protein: P19491 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 60423.97 |
| 構造登録者 | Krintel, C.,Frydenvang, K.,Gajhede, M.,Kastrup, J.S. (登録日: 2011-08-26, 公開日: 2011-09-21, 最終更新日: 2024-10-30) |
| 主引用文献 | Krintel, C.,Frydenvang, K.,Olsen, L.,Kristensen, M.T.,de Barrios, O.,Naur, P.,Francotte, P.,Pirotte, B.,Gajhede, M.,Kastrup, J.S. Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2. Biochem.J., 441:173-178, 2012 Cited by PubMed Abstract: Positive allosteric modulators of the ionotropic glutamate receptor-2 (GluA2) are promising compounds for the treatment of cognitive disorders, e.g. Alzheimer's disease. These modulators bind within the dimer interface of the LBD (ligand-binding domain) and stabilize the agonist-bound conformation slowing receptor desensitization and/or deactivation. In the present study, we employ isothermal titration calorimetry to determine binding affinities and thermodynamic details of binding of modulators of GluA2. A mutant of the LBD of GluA2 (LBD-L483Y-N754S) that forms a stable dimer in solution was used. The potent GluA2 modulator BPAM-97 was used as a reference compound. Evidence that BPAM-97 binds in the same pocket as the well-known GluA2 modulator cyclothiazide was obtained from X-ray structures. The LBD-L483Y-N754S:BPAM-97 complex has a Kd of 5.6 μM (ΔH=-4.9 kcal/mol, -TΔS=-2.3 kcal/mol; where 1 kcal≈4.187 kJ). BPAM-97 was used in a displacement assay to determine a Kd of 0.46 mM (ΔH=-1.2 kcal/mol, -TΔS=-3.3 kcal/mol) for the LBD-L483Y-N754S:IDRA-21 complex. The major structural factors increasing the potency of BPAM-97 over IDRA-21 are the increased van der Waals contacts to, primarily, Met496 in GluA2 imposed by the ethyl substituent of BPAM-97. These results add important information on binding affinities and thermodynamic details, and provide a new tool in the development of drugs against cognitive disorders. PubMed: 21895609DOI: 10.1042/BJ20111221 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.45 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






